Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn L Nash

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|January 29, 2010
A massive haematemesisKathryn L Nash, Gideon M Hirschfield
Advances in Therapy|July 24, 2010
Telaprevir: a new hope in the treatment of chronic hepatitis C?Andrew J Fowell, Kathryn L Nash
Hospital Medicine (London, England : 1998)|May 7, 2003
Liver transplantationKathryn L Nash, Alexander E S Gimson
The Lancet. Infectious Diseases|May 20, 2008
The case for combination antiviral therapy for chronic hepatitis B virus infectionKathryn L Nash, Graeme J M Alexander
BMJ (Clinical Research Ed.)|June 30, 2009
Managing hepatitis C virus infectionKathryn L Nash, Ian Bentley, Gideon M Hirschfield
Transplant International : Official Journal of the European Society for Organ Transplantation|October 20, 2007
Is cyclosporin the immunosuppressant of choice for liver transplantation for erythropoietic protoporphyria?Kathryn L Nash, Timothy M Cox, Graeme J M Alexander
World Journal of Gastroenterology|November 13, 2010
Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile ratesMatthew R L Brown, Graeme Jones, Kathryn L Nash, et al.
World Journal of Gastroenterology|August 24, 2010
Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosisKathryn L Nash, Tracy Woodall, Ashley S M Brown, et al.
The Journal of Gene Medicine|September 8, 2004
Hepatocyte-specific gene expression from integrated lentiviral vectorsKathryn L Nash, Bushra Jamil, Alison J Maguire, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|January 29, 2010
A massive haematemesisKathryn L Nash, Gideon M Hirschfield
Advances in Therapy|July 24, 2010
Telaprevir: a new hope in the treatment of chronic hepatitis C?Andrew J Fowell, Kathryn L Nash
Hospital Medicine (London, England : 1998)|May 7, 2003
Liver transplantationKathryn L Nash, Alexander E S Gimson
The Lancet. Infectious Diseases|May 20, 2008
The case for combination antiviral therapy for chronic hepatitis B virus infectionKathryn L Nash, Graeme J M Alexander
BMJ (Clinical Research Ed.)|June 30, 2009
Managing hepatitis C virus infectionKathryn L Nash, Ian Bentley, Gideon M Hirschfield
Transplant International : Official Journal of the European Society for Organ Transplantation|October 20, 2007
Is cyclosporin the immunosuppressant of choice for liver transplantation for erythropoietic protoporphyria?Kathryn L Nash, Timothy M Cox, Graeme J M Alexander
World Journal of Gastroenterology|November 13, 2010
Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile ratesMatthew R L Brown, Graeme Jones, Kathryn L Nash, et al.
World Journal of Gastroenterology|August 24, 2010
Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosisKathryn L Nash, Tracy Woodall, Ashley S M Brown, et al.
The Journal of Gene Medicine|September 8, 2004
Hepatocyte-specific gene expression from integrated lentiviral vectorsKathryn L Nash, Bushra Jamil, Alison J Maguire, et al.
Pageof 1